VolitionRX Limited

(VNRX)

By |

Profile

VolitionRX Ltd is a US-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.

Contact Information

Website: www.volitionrx.com
Email: investorrelations@volitionrx.com
Address: 1 Scotts Road
Address 2: Number 24-05 Shaw Centre
City / Town: Singapore
Country: SGP
Postal Code: 228208

Issuer Information

Exchange: AMX
CEO: Cameron John. Reynolds
Employees: 37
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 2.07 $ -0.03 (-1.43%)
Last Price 2.07 Change $ -0.03 Change % -1.43 Tick N/A
Bid 2.00 Bid Size 1,400.00 Ask 2.82 Ask Size 3,000.00
Open 2.21 High 2.22 Low 2.07 Prev Close 2.10
Last Trade Volume 61,621 52 Wk Hi 4.00 52 Wk Low 1.44
Market Cap 62.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 30,031,225.00 EPS (TTM) -0.62 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 3
Number of Buys 0 3
Number of Sells 0 0
Net Activity 0 10010
Last 10 Buys Shares
David Vanston 1,000
Rodney Gerard Rootsaert 1,000
Cameron John. Reynolds 1,000
David M. Kratochvil 1,000
Cameron John. Reynolds 1,000
Cameron John. Reynolds 1,000
Guy Innes 1,000
Guy Innes 1,000
Guy Innes 1,000
Guy Innes 1,000
Last 10 Sell Shares
Cameron John. Reynolds 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8 8 8 8
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 6.6 6.6 6.67 6.6
Standard Deviation 1.14 1.14 1.53 1.14
Date of Most Recent Estimate 06/04/18 05/23/18 05/18/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 1 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1